Hagino T, Ikegame K, Tanaka H, Kanda Y, Kaida K, Fukuda T, Kondo Y, Sato M, Doki N, Nakamae H, Matsuoka KI, Mori Y, Sano H, Eto T, Kawakita T, Hashii Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of Japanese Society for Transplantation, Cellular Therapy.  Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation. Int J Hematol. 2025 Mar 20. doi: 10.1007/s12185-025-03952-y. Online ahead of print.

Takahashi N, Mochizuki K, Kikuta A, Ohara Y, Kudo S, Ikeda K, Ohto H, Sano H.　Graft CD8⁺ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies.      Int J Hematol. 2025 Mar;121(3):403-410. doi: 10.1007/s12185-024-03900-2. Epub 2024 Dec 10.PMID: 39656374

Sakaguchi H, Taga T, Ishida H, Hama A, Okamoto Y, Sano H, Sato M, Koga Y, Koh K, Iwasaki F, Yoshida N, Cho Y, Okada K, Watanabe K, Watanabe A, Hasegawa D, Noguchi M, Hashii Y, Matsumoto K, Tabuchi K; Pediatric Acute Myeloid Leukemia Working Group of Japanese Society for Transplantation and Cellular Therapy. Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study. Bone Marrow Transplant. 2024 Nov;59(11):1621-1624. doi: 10.1038/s41409-024-02396-y.

Ogawa I, Hakozaki M, Kaneuchi Y, Suzuki T, Nikaido T, Yamada S, Utsumi A, Hasegawa O, Sano H, Matsumoto Y.   Case report: Atypical lipomatous tumor of the thigh in a  four-year-old girl. Front Oncol. 2024 Jul 23;14:1401861. doi:10.3389/fonc.2024.1401861.

Uchihara Y, Umeda K, Yamada Y, Ito H, Tasaka K, Isobe K, Akazawa R, Kawabata N, Saida S, Kato I, Hiramatsu H, Noguchi T, Sakamoto A, Arakawa Y, Arakawa A, Yamamoto N, Hosoya Y, Uemura S, Watanabe KI, Sano H, Taga T, Takita J. MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma. Cancer Sci. 2024 Oct;115(10):3394-3402. doi: 10.1111/cas.16297.

Ishida H, Imamura T, Kobayashi R, Hashii Y, Deguchi T, Miyamura T, Oda M, Yamamoto M, Okada K, Sano H, Koh K, Yuza Y, Watanabe K, Nishimura N, Takimoto T, Moriya-Saito A, Sekimizu M, Suenobu S, Sunami S, Horibe K. Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Cancer Med. 2024 Jun;13(12):e7246. doi: 10.1002/cam4.7246.

Naruse Y, Jinguji S, Hiruta R, Toda A, Nagai K, Kudo S, Sano H, Sekine R, Suzuki O, Bakhit M, Fujii M. Bifocal germ cell tumor of pineal germinoma and neurohypophyseal embryonal carcinoma: illustrative case. J Neurosurg Case Lessons. 2024 Mar 4;7(10): CASE23718. doi: 10.3171/CASE23718. Print 2024 Mar 4.

Yamanaka J, Ogawa C, Arakawa A, Deguchi T, Hori T, Kiyokawa N, Ueki H, Nishi M, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Koh K, Hasegawa D, Ogawa A, Watanabe K, Sato A, Saito AM, Watanabe T, Manabe A, Horibe K, Goto H, Toyoda H.   Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.  Pediatr Blood Cancer. 2024 Dec;71(12):e31319. doi: 10.1002/pbc.31319. Epub 2024 Sep 12.

Ogawa A, Kawamoto H, Hara J, Kikuta A, Ogawa C, Hiraga H, Yoshimura K, Miyairi K, Omori R, Ro T, Kamei Y, Kimura T. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy. Cancer Chemother Pharmacol. 2024 Jul;94(1):89-101. doi: 10.1007/s00280-024-04664-6. Epub 2024 Mar 13.

Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Igarashi S, Sato A, Hori T, Saito AM, Watanabe T, Deguchi T, Manabe A, Horibe K, Toyoda H.  TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. Int J Hematol
. 2024 Apr;119(4):450-458. doi: 10.1007/s12185-024-03710-6. Epub 2024 Jan 25.

Miyagawa N, Goto H, Ogawa A, Kikuta A, Kosaka Y, Sekimizu M, Tomizawa D, Toyoda H, Hiramatsu H, Hara J, Mochizuki S, Nakayama H, Yoshimura K, Iijima-Yamashita Y, Sanada M, Ogawa C.  Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.  Int J Hematol. 2023 Aug;118(2):267-276. doi: 10.1007/s12185-023-03609-8. Epub 2023 May 1.

Nishimura A, Yokoyama K, Naruto T, Yamagishi C, Imamura T, Nakazono H, Kimura S, Ito M, Sagisaka M, Tanaka Y, Piao J, Namikawa Y, Yanagimachi M, Isoda T, Kanai A, Matsui H, Isobe T, Sato-Otsubo A, Higuchi N, Takada A, Okuno H, Saito S, Karakawa S, Kobayashi S, Hasegawa D, Fujisaki H, Hasegawa D, Koike K, Koike T, Rai S, Umeda K, Sano H, Sekinaka Y, Ogawa A, Kinoshita A, Shiba N, Miki M, Kimura F, Nakayama H, Nakazawa Y, Taga T, Taki T, Adachi S, Manabe A, Koh K, Ishida Y, Takita J, Ishikawa F, Goto H, Morio T, Mizutani S, Tojo A, Takagi M. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type. Sci Adv. 2023 Dec 15;9(50):eadj4407. doi: 10.1126/sciadv.adj4407. Epub 2023 Dec 13.

Takahashi N, Mochizuki K, Kobayashi S, Ohara Y, Kudo S, Saito Y, Ikeda K, Ohto H, Kikuta A, Sano H.　T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for a Patient With Tcf3-Hlf-Positive Acute Lymphoblastic Leukemia Extramedullary Relapse After Unrelated Bone Marrow Transplantation. J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e419-e422. doi: 10.1097/MPH.0000000000002555. Epub 2022 Sep 22.

Fukaya Y, Kimura T, Hamada Y, Yoshimura K, Hiraga H, Yuza Y, Ogawa A, Hara J, Koh K, Kikuta A, Koga Y, Kawamoto H.  Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy.  Front Oncol. 2023 Jan 30:13:1003633. doi: 10.3389/fonc.2023.1003633. eCollection 2023.

Mochizuki K.  Harnessing allogeneic CD4+ T cells to reinvigorate host endogenous antitumor immunity.  Fukushima J Med Sci. 2023 Nov 15;69(3):157-165. doi: 10.5387/fms.23-00001. Epub 2023 Oct 26.

Kobayashi S, Sano H, Mochizuki K, Ohara Y, Takahashi N, Kudo S, Ikeda K, Ohto H, Kikuta A.   Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation. Int J Hematol.  115(3):414-423, 2022.

Honda Y, Muramatsu H, Nanjo Y, Hirabayashi S, Meguro T, Yoshida N, Kakuda H, Ozono S, Wakamatsu M, Moritake H, Yasui M, Sano H, Manabe A, Sakashita K.　A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia. Int J Hematol.;115:263-268, 2022.

Minakawa K, Ono S, Watanabe M, Sato Y, Suzuki S, Odawara S, Kawabata K, Ueda K, Nollet KE, Sano H, Ikezoe T, Kikuta A, Ikeda K. Evaluation of a quantitative PCR-based method for chimerism analysis of Japanese donor/recipient pairs. Sci Rep. 2022 Dec 9;12(1):21328. doi: 10.1038/s41598-022-25878-9.

Endo Y, Watanabe T, Saito M, Saito K, Suzuki R, Sano H, Natori Y, Sasaki E, Ueda M, Kamo N, Furukawa S, Soeda S, Kono K, Saji S, Fujimori K. A rare case of recurrent ovarian cancer with TPM3-NTRK1gene rearrangement: A case report. Mol Clin Oncol. 2022 Apr;16(4):90. doi: 10.3892/mco.2022.2523. Epub 2022 Feb 23.

Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, Nakamae H, Matsuoka KI, Ara T, Washio K, Onizuka M, Watanabe K, Takahashi Y, Hirakawa T, Nishio M, Sakashita C, Kobayashi T, Sawada A, Ichinohe T, Fukuda T, Hashii Y, Atsuta Y, Arai A. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022 Jun 1;97(6):780-790. doi: 10.1002/ajh.26544. Epub 2022 Mar 30.

Sano H, Mochizuki K, Kobayashi S, Ohara Y, Takahashi N, Kudo S, Waragai T,Ikeda K, Ohto H, Kikuta A. Effectiveness of T-cell replete haploidentical hematopoietic stem cell transplantation for refractory/relapsed B cell acute lymphoblastic leukemia in children and adolescents. Front Pediatr. 2021 Oct 13;9:743294. doi: 10.3389/fped.2021.743294. eCollection 2021.

Mochizuki K, Kobayashi S, Takahashi N, Sugimoto K, Sano H, Ohara Y, Mineishi S, Zhang Y, Kikuta A. Alloantigen-activated (AAA) CD4 ⁺ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice. J Exp Clin Cancer Res. 2021 Oct 8;40(1):314. doi: 10.1186/s13046-021-02102-6.

Takahashi N, Mochizuki K, Sano H, Kobayashi S, Ohara Y, Ikeda K, Ohto H, Kikuta A.  Decline of serum albumin precedes severe acute GVHD after haploidentical HSCT. Pediatr Int. 2021 Sep;63(9):1048-1054. doi: 10.1111/ped.14564. Epub 2021 Jul 14.

Kada A, Kikuta A, Saito AM, Kato K, Iguchi A, Yabe H, Ishida H, Hyakuna N, Takahashi Y, Nagasawa M, Hashii Y, Umeda K, Matsumoto K, Fujisaki H,Yano M, Nakazawa Y, Sano H.  Single-Arm Non-Blinded Multicenter Clinical Trial on T-Cell-Replete Haploidentical Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin for Relapsed and Refractory Pediatric Acute Leukemia. Kurume Med J. 2021 Oct 6;66(3):161-168. doi: 10.2739/kurumemedj.MS663004. Epub 2021 Aug 20.

Sano H, Mochizuki K, Kobayashi S, Ohara Y, Takahashi N, Kudo S, Ikeda K, Ohto H, Kikuta A. T-cell replete haploidentical stem cell transplantation with low dose anti-thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors. Cancer Rep (Hoboken). 2022 Jul;5(7):e1519. doi: 10.1002/cnr2.1519. Epub 2021 Jul 22.

Takahashi N, Sano H, Mochizuki K, Kobayashi S, Ohara Y, Kikuta A.　Intracranial Hemorrhage in a Pediatric Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report. Case Rep Oncol. 2021 Mar 22;14(1):525-530. doi: 10.1159/000515011. eCollection 2021 Jan-Apr.

Umeda K, Miyamura T, Yamada K, Sano H, Hosono A, Sumi M, Okita H, Kumamoto T, Kawai A, Hirayama J, Jyoko R, Sawada A, Nakayama H, Hosoya Y, Maeda N, Yamamoto N, Imai C, Hasegawa D, Chin M, Ozaki T.  Clinical outcome of patients with recurrent or refractory localized Ewing’s sarcoma family of tumors: a retrospective report from the Japan Ewing Sarcoma Study Group. Cancer Rep (Hoboken). 2021 Jun;4(3):e1329. doi: 10.1002/cnr2.1329. Epub 2021 Jan 16.

Umeda K, Miyamura T, Yamada K, Sano H, Hosono A, Sumi M, Okita H, Kamio T, Maeda N, Fujisaki H, Joko R, Watanabe A, Hosoya Y, Hasegawa D, TakenakaS, Nakagawa S, Chin M, Ozaki T.; Japan Ewing Sarcoma Study Group. Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing’s sarcoma family of tumors: a retrospective report from the Japan Ewing Sarcoma Study Group. Pediatr Blood Cancer. 2021 Mar;68(3):e28844. doi: 10.1002/pbc.28844. Epub 2020 Dec 19.

Yabe M, Morio T, Tabuchi K, Tomizawa D, Hasegawa D, Ishida H, Yoshida N,Koike T,Takahashi Y, Koh K, Okamoto Y, Sano H, Kato K, Kanda Y, Goto H, Takita J, Miyamura T, Noguchi M, Kato K, Hashii Y, Astuta Y, Yabe H.　Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis. Int J Hematol. 2021 Jan;113(1):134-144. doi: 10.1007/s12185-020-02991-x. Epub 2020 Sep 19.

Saito Y, Urashima M, Takahashi Y, Ogawa A, Kiyotani C, Yuza Y, Koh K, Watanabe K, Kosaka Y, Goto H, Kikuta A, Okada K, Koga Y, Fujimura J, Inoue M, Sato A, Atsuta Y, Matsumoto K.  Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.  Bone Marrow Transplant. 2021 Sep;56(9):2173-2182. doi: 10.1038/s41409-021-01303-z. Epub 2021 Apr 28.

Nakagawa S, Kato M, Imamura T, Imai C, Koh K, Kawano Y, Shimomura Y, Watanabe A, Kikuta A, Saito A, Horibe K, Manabe A, Ohara A, Okamoto Y.  In-Hospital Management Might Reduce Induction Deaths in Pediatric Patients With Acute Lymphoblastic Leukemia: Results From a Japanese Cohort.  J Pediatr Hematol Oncol. 2021 Mar 1;43(2):39-46. doi: 10.1097/MPH.0000000000001926.

Yanagimachi M, Kato K, Iguchi A, Sasaki K, Kiyotani C, Koh K, Koike T, Sano H, ShigemuraT, Muramatsu H, Okada K, Inoue M, Tabuchi K, Nishimura T, Mizukami T, Nunoi H, Imai K, Kobayashi M, Morio T.　Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.  Front Immunol. 2020 Jul 29;11:1617. doi: 10.3389/fimmu.2020.01617. eCollection 2020.

Sano H, Mochizuki K, Kobayashi S, Ono S, Ikeda K, Ohto H, Kikuta A. Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell TransplantationFrom Different Family Donors with KIR Ligand Mismatch. J Pediatr Hematol Oncol. 42(2):e104-e106, 2020.

Chin M, Yokoyama R, Sumi M, Okita H, Kawai A, Hosono A, Koga Y,  Sano H, Watanabe H, Ozaki T, Mugishima H; Japan Ewing Sarcoma Study Group (JESS).　Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing SarcomaStudy 04. Pediatr Blood Cancer. 2020 May;67(5):e28194. doi: 10.1002/pbc.28194. Epub 2020 Feb 20..

Kimura S, Ohkawara H, Minakawa K, Fukatsu M, Mori H, Takahashi H, Harada-Shirado K, Ohara Y, Takahashi N, Mochizuki K, Sano H, Nollet KE, Ogawa K, Ohto H, Kikuta A, Ikeda K, Ikezoe T. Optimal timing of apheresis for the efficient mobilization of peripheral blood progenitor cells recruited by high-dose granulocyte colony-stimulating factor in healthy donors. Transfus Apher Sci. 2020 Jun;59(3):102737. doi: 10.1016/j.transci.2020.102737. Epub 2020 Feb 5.

Okamoto Y, Nakazawa Y, Inoue M, Watanabe K, Goto H, Yoshida N, Noguchi M, Kikuta A, Kato K, Hashii Y, Atsuta Y, Kato M.  Hematopoietic stem cell transplantation in children and adolescents with nonremission acute lymphoblastic leukemia.  Pediatr Blood Cancer. 2020 Dec;67(12):e28732. doi: 10.1002/pbc.28732. Epub 2020 Sep 22.

Iehara T, Yoneda A, Kikuta A, Muraji T, Tokiwa K, Takahashi H, Teramukai S, Takimoto T, Yagyu S, Hosoi H, Tajiri T; Japan Children’s Cancer Group Neuroblastoma Committee.  A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol.  BMC Pediatr
. 2020 May 12;20(1):212. doi: 10.1186/s12887-020-02061-5.

Kobayashi R, Inoue M, Takahashi Y, Kikuta A, Ogawa A, Koga Y, Koh K, Hashii Y, Hara J, Kato K, Tabuchi K, Matsumoto K.  Autologous Stem Cell Transplantation for Children With Renal Tumors, and Adults With Wilms Tumor: Retrospective Analysis of the Japanese Transplant Registry Unified Management Program.  J Pediatr Hematol Oncol. 2020 May;42(4):251-255. doi: 10.1097/MPH.0000000000001779.

Yaginuma K, Watanabe M, Saito Y, Takahashi N, Ohara Y, Kobayashi S, Mochizuki K, Suyama K, Sato M, Sano H, Hashimoto K, Kikuta A, Hosoya M. Pneumorrhachis in children: A report of two cases and review of the literature.Radiol Case Rep. 14(11):1325-1329, 2019.

Ishimaru S, Okamoto Y, Imai C, Sakaguchi H, Taki T, Hasegawa D, Cho Y, Kakuda H, Sano H, Manabe A, Imamura T, Kato M, Arakawa Y, Shimonodan H,Sato A, Suenobu S, Inukai T,Watanabe A, Kawano Y, Kikuta A, Horibe K, Ohara A, Koh K. Nationwide survey of pediatrichypodiploid acute lymphoblastic leukemia in Japan. Pediatr Int. 61(11):1103-1108, 2019.

Mochizuki K, Kawana S, Yamada S, Muramatsu M, Sano H, Kobayashi S, Ohara Y, Takahashi N, Hakozaki M, Yamada H, Hashimoto Y, Kikuta A, Various checkpoint molecules, and tumor-infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy. Pediatr Hematol Oncol, 36(1):17-27, 2019.

Sano H, Mochizuki K, Kobayashi S, Ono S, Ikeda K, Ohto H, Kikuta A, Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell Transplantation From Different Family Donors With KIR Ligand Mismatch. J Pediatr Hematol, doi: 10.1097/MPH.0000000000001443, 2019.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H, Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol, 4(3):404-413, 2019.

Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C, Honma K, Mitsui-Sekinaka K, Sekinaka Y, Kato T, Hanabusa K, Endo E, Takashima T, Hiroki H, Yeh TW, Tanaka K, Nagahori M, Tsuge I, Bando Y, Iwasaki F, Shikama Y, Inoue M, Kimoto T, Moriguchi N, Yuza Y, Kaneko T, Suzuki K, Matsubara T, Maruo Y, Kunitsu T, Waragai T, Sano H, Hashimoto Y, Tasaki K, Suzuki O, Shirakawa T, Kato M, Uchiyama T, Ishimura M, Tauchi T, Yagasaki H, Jou ST, Yu HH, Kanegane H, Kracker S, Durandy A, Kojima D, Muramatsu H, Wada T, Inoue Y, Takada H, Kojima S, Ogawa S, Ohara O, Nonoyama S, Morio T, Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1. J Allergy Clin Immunol, 143(1):266-275, 2019.

Miller L, Kobayashi S, Pauly M, Lew G, Saxe D, Keller F, Qayed M, Castellino S, Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL). Br J Haematol, 185(3):613-616, 2019.

Yakushijin K, Ikezoe T, Ohwada C, Kudo K, Okamura H, Goto H, Yabe H, Yasumoto A, Kuwabara H, Fujii S, Kagawa K, Ogata M, Onishi Y, Kohno A, Watamoto K, Uoshima N, Nakamura D, Ota S, Ueda Y, Oyake T, Koike K, Mizuno I, Iida H, Katayama Y, Ago H, Kato K, Okamura A, Kikuta A, Fukuda T, Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 54:674-680, 2019.

Fujii M, Ichikawa M, Iwatate K, Bakhit M, Yamada M, Kuromi Y, Sato T, Sakuma J, Sato H, Kikuta A, Suzuki Y, Saito K. Secondary brain tumors after cranial radiation therapy: A single-institution study.  Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):245-249. doi: 10.1016/j.rpor.2020.01.009. Epub 2020 Jan 30.

Miyachi M, Tsuchiya K, Hosono A, Ogawa A, Koh K, Kikuta A, Hara J, Teramukai S, Hosoi H.  Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol.  Medicine (Baltimore). 2019 Dec;98(52):e18344. doi: 10.1097/MD.0000000000018344.

Hasegawa D, Yoshimoto Y, Kimura S, Kumamoto T, Maeda N, Hara J, Kikuta A, Kada A, Kimura T, Iijima-Yamashita Y, Saito AM, Horibe K, Manabe A, Ogawa C.  Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia.  Int J Hematol. 2019 Nov;110(5):627-634. doi: 10.1007/s12185-019-02714-x. Epub 2019 Aug 10.

Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T, Nakazawa A, Takimoto T, Kikuta A, Yagyu S, Ikeda H, Nakagawara A, Tajiri T; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).  Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children’s Cancer Group Neuroblastoma Committee.  Pediatr Blood Cancer. 2019 Nov;66(11):e27914. doi: 10.1002/pbc.27914. Epub 2019 Jul 24.

Sano H, Mochizuki K, Kobayashi S, Ohara Y, Ito M, Waragai T, Takahashi N, Ikeda K, Ohto H, Kikuta A, T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia. Int J Hematol, 108(1):76-84, 2018.

Takeda Y, Sano H, Kawano A, Mochizuki K, Takahashi N, Kobayashi S, Ohara Y, Tasaki K, Hosoya M, Kikuta A, Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report. J Med Case Rep,　12(1):119, 2018.

Mochizuki K, Sano H, Akaihata M, Kobayashi S, Waragai T, Ohara Y, Takahashi N, Ito M, Ikeda K, Ohto H, Kikuta A. T cell replete-haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies. Pediatr Transplant, 21(7), 2017.

Kobayashi S, Sano H, Mochizuki K, Ohara Y, Takahashi N, Ohto H, Kikuta A. Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation. Pediatr Int, 59(9):973-978, 2017.

Sano H, Mochizuki K, Akaihata M, Kobayashi S, Ohto H, Kikuta A. T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy. Pediatr Blood Cancer, 64(3), 2017.

Yoshihara H, Kumamoto T, Ono R, Akahane K, Nozaki T, Kobayashi S, Kikuta A, Matsumoto S, Hasegawa D, Ogawa C, Manabe A. Haploidentical hematopoietic cell transplantation for disseminated Ewing sarcoma. Pediatr Int, 59(2):223-226, 2017.

Kodama Y, Manabe A, Kawasaki H, Kato I, Kato K, Sato A, Matsumoto K, Kato M, Hiramatsu H, Sano H, Kaneko T, Oda M, Saito AM, Adachi S, Horibe K, Mizutani S,Ishii E, Shimada H.   Salvage therapy for children with relapsed or refractoryPhiladelphia chromosome-positive acute lymphoblastic leukemia.  Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26423. Epub 2017 Jan 13.

Ohara Y, Ohto H, Tasaki T, Sano H, Mochizuki K, Akaihata M, Kobayashi S, Waragai T, Ito M, Hosoya M, Nollet KE, Ikeda K, Ogawa C, Kanno T, Shikama Y, Kikuta A.　Comprehensive technical and patient-care optimization in the management of pediatric apheresis for peripheral blood stem cell harvesting. Transfus Apher Sci, 55(3):338-343, 2016.

Umemura K, Iwaki T, Kimura T, Ogawa C, Fukuda T, Taniguchi S, Horibe K, Goto H, Yoshimura K, Watanabe Y, Nitani C, Kikuta A. Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects. Clin Pharmacol Drug Dev, 5(6):548-551, 2016.

Koh K, Ogawa C, Okamoto Y, Kudo K, Inagaki J, Morimoto T, Mizukami H, Ecstein-Fraisse E, Kikuta A. Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan. Int J Hematol, 104(2):245-255, 2016.

Mochizuki K, Meng L, Mochizuki I, Tong Q, He S, Liu Y, Purushe J, Fung H, Zaidi MR, Zhang Y, Reshef R, Blazar BR, Yagita H, Mineishi S, Zhang Y. Programming of donor T cells using allogeneic delta-like ligand 4-positive dendritic cells to reduce GVHD in mice. Blood. 2016 May 3. pii: blood-2015-05-644476. [Epub ahead of print] PubMed PMID: 27143255.

Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, Ohki K, Yamashita Y, Kodama Y, Saito A, Mori M, Ishimaru S, Deguchi T, Hashii Y, Shimomura Y, Hori T, Kato K, Goto H, Ogawa C, Koh K, Taki T, Manabe A, Sato A, Kikuta A, Adachi S, Horibe K, Ohara A, Watanabe A, Kawano Y, Ishii E, Shimada H. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. Blood Cancer J, 6(5):e419, 2016.

Meng L, Bai Z, He S, Mochizuki K, Liu Y, Purushe J, Sun H, Wang J, Yagita H, Mineishi S, Fung H, Yanik GA, Caricchio R, Fan X, Crisalli LM, Hexner EO, Reshef R, Zhang Y, Zhang Y. The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation. J Immunol, 196(3):1070-1080, 2016.

Kobayashi S, Kawasaki Y, Sano H, Mochizuki K, Hosoya M, Kikuta A. Long-term remission of HSCT-related NS after a second allogenic stem cell transplant. Pediatr Nephrol. 2015 Dec 11. [Epub ahead of print] PubMed PMID: 26659462.

Huang Y, Clarke F, Karimi M, Roy NH, Williamson EK, Okumura M, Mochizuki K, Chen EJ, Park TJ, Debes GF, Zhang Y, Curran T, Kambayashi T, Burkhardt JK. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015 Mar 2;125(3):1019-32. doi: 10.1172/JCI77278.

Tomizawa D, Watanabe T, Hanada R, Horibe K, Horikoshi Y, Iwamoto S,Kinoshita A, Moritake H, Nakayama H, Shimada A, Taga T, Takahashi H,Tawa A, Terui K, Hori H, Kawano Y, Kikuta A, Manabe A, Adachi S.Outcome of adolescent patients with　acute myeloid leukemia treated　with pediatric protocols. Int J Hematol. 2015　Sep;102(3):318-26. doi:　10.1007/s12185-015-1825-x. Epub 2015 Jul 1. PubMed PMID: 26126642.

Tong Q, He S, Xie F, Mochizuki K, Liu Y, Mochizuki I, Meng L, Sun H, Zhang Y, Guo Y, Hexner E, Zhang Y. Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice. J Immunol. 2014 Jun 1;192(11):5012-22. doi: 10.4049/jimmunol.1302943.

Kobayashi S, Ito M, Sano H, Mochizuki K, Akaihata M, Waragai T, Ohara Y, HosoyaM, Kikuta A. Idiopathic Hyperammonemia That Developed During Initial Treatment With Steroid in a Patient With Newly Diagnosed Leukemia. J Pediatr Hematol Oncol, doi:10.1097/MPH.0000000000000255, 2014.

Kobayashi S, Ito M, Sano H, Mochizuki K, Akaihata M, Waragai T, Ohara Y, Hosoya M, Ohto H , Kikuta A, T-cell-replete haploidentical stem cell transplantation is highly　efficacious for relapsed and refractory childhood acute　leukaemia, Transfusion Med, doi: 10.1111/tme.12150, 2014.

Kobayashi S, Waragai T, Sano H, Mochizuki K, Akaihata M, Ohara Y, Hosoya M, Kikuta A. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments. Anticancer Drugs, Oct;25 (9):1102-5. doi: 10.1097/CAD.0000000000000143, 2014.

Asai D, Imamura T, Yamashita Y, Suenobu S, Moriya-Saito A, Hasegawa D, Deguchi T, Hashii Y, Endo M, Hatakeyama N, Kawasaki H, Hori H, Horibe K, Yumura-Yagi K, Hara J, Watanabe A, Kikuta A, Oda M, Sato A; Japan Association of Childhood Leukemia Study (JACLS) & Children’s Cancer and Leukemia Study Group (CCLSG). Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children’s Cancer and Leukemia Study Group (CCLSG). Cancer Med, Jun;3(3):623-31. doi: 10.1002/cam4.221, 2014.

Kobayashi S, Kikuta A, Ito M, Sano H, Mochizuki K, Akaihata M, Waragai T, Ohara Y, Ogawa C, Ono S, Ohto H, Hosoya M. Loss of mismatched HLA in myeloid/NK cell precursor acute leukemia relapse after T cell-replete haploidentical hematopoietic stem cell transplantation. Pediatr Blood Cancer, Oct;61(10):1880-2. doi: 10.1002/pbc.24962, 2014.

Suganuma R, Wang LL, Sano H, Naranjo A, London WB, Seeger RC, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Amann G, Beiske K, Cullinane CJ, d’Amore ES, Gambini C, Jarzembowski JA, Joshi VV, Navarro S, Peuchmaur M, Shimada H. Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children’s Oncology Group and the International Neuroblastoma Pathology Committee. Pediatr Blood Cancer. 2013 Mar;60(3):363-70.doi: 10.1002/pbc.24238.

He S, Xie F, Liu Y, Tong Q, Mochizuki K, Lapinski PE, Mani RS, Reddy P,Mochizuki I, Chinnaiyan AM, Mineishi S, King PD, Zhang Y. The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease. Blood. 2013 Dec 12;122(25):4119-28. doi:10.1182/blood-2013-05-505180.

Mochizuki K, Xie F, He S, Tong Q, Liu Y, Mochizuki I, Guo Y, Kato K, Yagita H, Mineishi S, Zhang Y. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice. J Immunol. 2013 Apr 1;190(7):3772-82. doi: 10.4049/jimmunol.1202820.

Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, Kogawa K, Kawakami C, Horikoshi Y, Iwai T, Okamoto Y, Tsurusawa M, Asami K; for The Japanese Childhood Cancer and Leukemia Study Group. Assessment of Corticosteroid- induced Osteonecrosis in Children Undergoing Chemotherapy for Acute Lymphoblastic Leukemia: A Report From the Japanese Childhood Cancer and Leukemia Study Group. JPediatr Hematol Oncol, Oct 23
doi:10.1097/MPH.0000000000000039, 2013.

Ikeda K, Ohto H, Kanno T, Gonda K, Suzuki Y, Ono T, Saito S, Takahashi H, Kimura S, Harada-Shirado K, Yamauchi H, Hoshino Y, Mashimo Y, Nollet KE, Kikuta A, Ogawa K, Takeishi Y. Peripheral blood progenitor cell collection by two programs forautologous and allogeneic transplantation. Transfusion, Oct 9 doi:10.1111/trf.12437, 2013.

Yamashita Y, Shimada A, Yamada T, Yamaji K, Hori T, Tsurusawa M, Watanabe A, Kikuta A, Asami K, Saito AM, Horibe K. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer, 60, 1587-92, 2013.

Hakozaki M, Hojo H, Tajino T, Yamada H, Kikuchi S, Kikuta A, Konno S, Abe M. Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change ofthe PAX3-FKHR chimeric fusion gene: a case study. Hum Cell, Jun 25 doi:10.1007/s13577-013-0067-6, 2013.

Kato M, Matsumoto K, Suzuki R, Yabe H, Inoue M, Kigasawa H, Inagaki J, Koh K, HashiiY, Tauchi H, Suminoe A, Kikuta A, Sakamaki H, Kawa K, Kato K, Fukuda T. Salvage allogeneic hematopoietic SCT for primary graft failure in children. Bone Marrow Transplant, 48, 1173-8, 2013.

Kobayashi S, Ito M, Sano H, Mochizuki K, Akaihata M, Waragai T, Hosoya M, Kikuta A,　Clinical analysis of combination therapy for febrile neutropenic patients in childhood cancer.　Pediatr Int.55, 65-71, 2013.

Akaihata M, Kikuta A, Mochizuki K, Nemoto K, Ito M, Sano H, Kobayashi S, Ohto H, Hosoya M. Maintenance of surface antigens and the absence of an apoptotic marker are observed during storage of granulocyte concentrates collected by bag separation method. Transfusion and Apheresis Science 47, 43–47, 2012.

Iida M, Suzuki　R, Yoshida　T, Ishiyama K, Kaya H, Taguchi J, Kikuta A, Kahata　K, Ohno　E, Miyamura K, Kodera Y.　Outpatient peripheral blood stem cell collection in Japan: Donor follow-up　survey by the Japan Society for Hematopoietic Cell Transplantation ．　Journal of Hematopoietic Cell Transplantation, 1, 52-58, 2012.

Oda K, Sato T, Watanabe T, Ichikawa M, Ito E, Matsumoto Y, Ando H, Sakuma J, Kikuta A, Hojo H, Saito K.　Radiation-induced World Health Organization grade II meningiomas in young patients following prophylactic cranial irradiation for acute lymphoblastic leukemia in childhood. Three case reports.　Neurol Med Chir, 52, 224-8, 2012.

Ngoma AM, Ikeda K , Hashimoto Y, Mochizuki K , Takahashi H, Sano H, Matsumoto H, Noji H, Saito S, Kikuta A, Ogawa K , Ohtsuka M, Abe M, Nollet KE , Ohto H. Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int J Hematol, 95, 86-94, 2012.

Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A,　Kawa K, Ohshima K, Nakamura S. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.Blood, 119, 673-86, 2012.

Marachelian A, Shimada H, Sano H, Jackson H, Stein J, Sposto R, Matthay KK, Baker D, Villablanca JG. The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma. Pediatr Blood Cancer. 2012 May;58(5):675-81.

He S, Wang J, Kato K, Xie F, Varambally S, Mineishi S, Kuick R, Mochizuki K, Liu Y, Nieves E, Mani RS, Chinnaiyan AM, Marquez VE, Zhang Y. Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. Blood. 2012 Feb 2;119(5):1274-82. doi: 10.1182/blood-2011-06-364422.